Epilepsy_Case_Presentation_Enhanced.pptx

Epilepsy case presentation, BSC pharmacy

1. Epilepsy – Patient Case Presentation Neurology Outpatient Clinic Case Prepared for Class/Clinic Presentation

2. General Patient Information Date of Admission: [Insert date] Patient’s Name: Mr. B Age: 22 years

3. Chief Complaint “I had another seizure last week while at home.”

4. History of Present Illness (HPI) - Epilepsy since age 15 - Generalized tonic-clonic seizures (2–3 minutes) - Post-ictal confusion - Last episode: 7 days ago during sleep - Frequency: 1–2/3 months, ↑ recently - Misses valproate 2–3x/week - Triggers: sleep deprivation, stress

5. Past Medical History (PMH) Epilepsy for 7 years No hypertension, diabetes, or CNS infections

6. Social History - University student - Lives with family - Non-smoker, no alcohol/drugs - Irregular sleep - Not driving

7. Family History Maternal uncle with epilepsy

8. Medication History Valproic acid 500 mg BID (poor adherence) No known drug allergies

9. Physical Examination Vitals: BP 116/74, HR 78, RR 16, afebrile General: alert, oriented Neuro: no focal deficits Other systems: unremarkable

10. Laboratory & Diagnostic Results EEG: abnormal epileptiform discharges MRI Brain: normal CBC, electrolytes, LFTs: normal Valproic acid level: subtherapeutic

11. Diagnosis Generalized Epilepsy – Suboptimally Controlled (poor adherence)

12. Medical Therapy Continue Valproic acid 500 mg BID Reinforce adherence Consider dose adjustment if uncontrolled Monitor LFTs and drug levels

13. Pharmaceutical Care – Assessment Poor seizure control due to non-adherence Subtherapeutic valproate levels

14. Pharmaceutical Care – Goals of Therapy Achieve seizure freedom or reduced frequency Minimize side effects Improve quality of life and safety

15. Pharmaceutical Care – Care Plan Education on adherence Sleep hygiene & stress reduction Avoid triggers (alcohol, flashing lights, sleep loss)

16. Pharmaceutical Care – Follow-up 1 month for review of adherence & seizures Repeat valproic acid levels Neurology follow-up every 3–6 months

17. Pharmaceutical Care – Intervention (Patient Education) Importance of taking meds on time Safety: no driving, avoid swimming alone/heights/machinery Family educated on seizure first aid